☰

Nicole C. Ammerman, Ph.D. - Publications

Affiliations: 
2009 Molecular Microbiology and Immunology University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Microbiology Biology
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kaushik A, Ammerman NC, Martins O, Parrish NM, Nuermberger EL. In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline Against Drug-Resistant Clinical Isolates of . Antimicrobial Agents and Chemotherapy. PMID 30962331 DOI: 10.1128/Aac.00470-19  0.308
2019 Saini V, Ammerman NC, Chang YS, Tasneen R, Chaisson RE, Jain S, Nuermberger E, Grosset JH. Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis. Antimicrobial Agents and Chemotherapy. PMID 30936097 DOI: 10.1128/Aac.00388-19  0.306
2018 Ammerman NC, Swanson RV, Bautista EM, Almeida DV, Saini V, Omansen TF, Guo H, Chang YS, Li SY, Tapley A, Tasneen R, Tyagi S, Betoudji F, Moodley C, Ngcobo B, et al. Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. PMID 29735562 DOI: 10.1128/Aac.00636-18  0.303
2017 Kaushik A, Ammerman NC, Tasneen R, Story-Roller E, Dooley KE, Dorman SE, Nuermberger EL, Lamichhane G. In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis. The Journal of Antimicrobial Chemotherapy. PMID 28575382 DOI: 10.1093/Jac/Dkx152  0.307
2016 Ammerman NC, Swanson RV, Tapley A, Moodley C, Ngcobo B, Adamson J, Dorasamy A, Moodley S, Mgaga Z, Bester LA, Singh SD, Almeida DV, Grosset JH. Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo. The Journal of Antimicrobial Chemotherapy. PMID 27798204 DOI: 10.1093/Jac/Dkw417  0.315
2016 Swanson R, Ammerman N, Ngcobo B, Adamson J, Moodley C, Dorasamy A, Moodley S, Mgaga Z, Bester LA, Singh SD, Almeida D, Grosset J. Clofazimine contributes sustained antimicrobial activity after treatment cessation in the mouse model of tuberculosis chemotherapy. Antimicrobial Agents and Chemotherapy. PMID 26926638 DOI: 10.1128/Aac.00177-16  0.333
2015 Kling A, Lukat P, Almeida DV, Bauer A, Fontaine E, Sordello S, Zaburannyi N, Herrmann J, Wenzel SC, König C, Ammerman NC, Barrio MB, Borchers K, Bordon-Pallier F, Brönstrup M, et al. Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins. Science (New York, N.Y.). 348: 1106-12. PMID 26045430 DOI: 10.1126/Science.Aaa4690  0.326
2015 Andréjak C, Almeida DV, Tyagi S, Converse PJ, Ammerman NC, Grosset JH. Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations. Antimicrobial Agents and Chemotherapy. 59: 2129-35. PMID 25624335 DOI: 10.1128/Aac.04841-14  0.309
2014 Almeida DV, Tyagi S, Li S, Wallengren K, Pym AS, Ammerman NC, Bishai WR, Grosset JH. Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice. Mycobacterial Diseases : Tuberculosis & Leprosy. 4: 145. PMID 25525563 DOI: 10.4172/2161-1068.1000145  0.37
2013 Lun S, Guo H, Onajole OK, Pieroni M, Gunosewoyo H, Chen G, Tipparaju SK, Ammerman NC, Kozikowski AP, Bishai WR. Indoleamides are active against drug-resistant mycobacterium tuberculosis Nature Communications. 4. PMID 24352433 DOI: 10.1038/Ncomms3907  0.315
2013 Grosset JH, Tyagi S, Almeida DV, Converse PJ, Li SY, Ammerman NC, Bishai WR, Enarson D, Trébucq A. Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice. American Journal of Respiratory and Critical Care Medicine. 188: 608-12. PMID 23822735 DOI: 10.1164/Rccm.201304-0753Oc  0.312
2013 Gupta S, Tyagi S, Almeida DV, Maiga MC, Ammerman NC, Bishai WR. Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor. American Journal of Respiratory and Critical Care Medicine. 188: 600-7. PMID 23805786 DOI: 10.1164/Rccm.201304-0650Oc  0.316
2013 Maiga M, Ammerman NC, Maiga MC, Tounkara A, Siddiqui S, Polis M, Murphy R, Bishai WR. Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment. The Journal of Infectious Diseases. 208: 512-9. PMID 23641020 DOI: 10.1093/Infdis/Jit187  0.318
2013 Onajole OK, Pieroni M, Tipparaju SK, Lun S, Stec J, Chen G, Gunosewoyo H, Guo H, Ammerman NC, Bishai WR, Kozikowski AP. Preliminary structure - Activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains Journal of Medicinal Chemistry. 56: 4093-4103. PMID 23611124 DOI: 10.1021/Jm4003878  0.331
2013 Andréjak C, Almeida DV, Tyagi S, Converse PJ, Ammerman NC, Grosset JH. Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy. The Journal of Antimicrobial Chemotherapy. 68: 659-65. PMID 23129730 DOI: 10.1093/Jac/Dks421  0.311
2012 Parthasarathy G, Lun S, Guo H, Ammerman NC, Geiman DE, Bishai WR. Rv2190c, an NlpC/P60 family protein, is required for full virulence of Mycobacterium tuberculosis. Plos One. 7: e43429. PMID 22952680 DOI: 10.1371/Journal.Pone.0043429  0.399
2012 Sears KT, Ceraul SM, Gillespie JJ, Allen ED, Popov VL, Ammerman NC, Rahman MS, Azad AF. Surface proteome analysis and characterization of surface cell antigen (Sca) or autotransporter family of Rickettsia typhi. Plos Pathogens. 8: e1002856. PMID 22912578 DOI: 10.1371/Journal.Ppat.1002856  0.714
2012 Larsson C, Luna B, Ammerman NC, Maiga M, Agarwal N, Bishai WR. Gene expression of Mycobacterium tuberculosis putative transcription factors whiB1-7 in redox environments. Plos One. 7: e37516. PMID 22829866 DOI: 10.1371/Journal.Pone.0037516  0.347
2012 Kaur SJ, Rahman MS, Ammerman NC, Beier-Sexton M, Ceraul SM, Gillespie JJ, Azad AF. TolC-dependent secretion of an ankyrin repeat-containing protein of Rickettsia typhi. Journal of Bacteriology. 194: 4920-32. PMID 22773786 DOI: 10.1128/Jb.00793-12  0.668
2012 Maiga M, Lun S, Guo H, Winglee K, Ammerman NC, Bishai WR. Risk of tuberculosis reactivation with tofacitinib (CP-690550). The Journal of Infectious Diseases. 205: 1705-8. PMID 22474037 DOI: 10.1093/Infdis/Jis269  0.322
2012 Maiga M, Agarwal N, Ammerman NC, Gupta R, Guo H, Maiga MC, Lun S, Bishai WR. Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model. Plos One. 7: e30749. PMID 22319585 DOI: 10.1371/Journal.Pone.0030749  0.313
2010 Rahman MS, Ammerman NC, Sears KT, Ceraul SM, Azad AF. Functional characterization of a phospholipase A(2) homolog from Rickettsia typhi. Journal of Bacteriology. 192: 3294-303. PMID 20435729 DOI: 10.1128/Jb.00155-10  0.727
2009 Ammerman NC, Gillespie JJ, Neuwald AF, Sobral BW, Azad AF. A typhus group-specific protease defies reductive evolution in rickettsiae. Journal of Bacteriology. 191: 7609-13. PMID 19820087 DOI: 10.1128/Jb.01077-09  0.615
2009 Gillespie JJ, Ammerman NC, Dreher-Lesnick SM, Rahman MS, Worley MJ, Setubal JC, Sobral BS, Azad AF. An anomalous type IV secretion system in Rickettsia is evolutionarily conserved. Plos One. 4: e4833. PMID 19279686 DOI: 10.1371/Journal.Pone.0004833  0.695
2009 Gillespie JJ, Ammerman NC, Beier-Sexton M, Sobral BS, Azad AF. Louse- and flea-borne rickettsioses: biological and genomic analyses. Veterinary Research. 40: 12. PMID 19036234 DOI: 10.1051/Vetres:2008050  0.602
2008 Ammerman NC, Beier-Sexton M, Azad AF. Laboratory maintenance of Rickettsia rickettsii. Current Protocols in Microbiology. Unit 3A.5. PMID 19016440 DOI: 10.1002/9780471729259.Mc03A05S11  0.582
2008 Ammerman NC, Beier-Sexton M, Azad AF. Growth and maintenance of Vero cell lines. Current Protocols in Microbiology. Appendix 4E. PMID 19016439 DOI: 10.1002/9780471729259.Mca04Es11  0.546
2008 Ammerman NC, Rahman MS, Azad AF. Characterization of Sec-translocon-dependent extracytoplasmic proteins of Rickettsia typhi. Journal of Bacteriology. 190: 6234-42. PMID 18641131 DOI: 10.1128/Jb.00794-08  0.684
2007 Gillespie JJ, Beier MS, Rahman MS, Ammerman NC, Shallom JM, Purkayastha A, Sobral BS, Azad AF. Plasmids and rickettsial evolution: insight from Rickettsia felis. Plos One. 2: e266. PMID 17342200 DOI: 10.1371/Journal.Pone.0000266  0.606
2004 Anderson JM, Ammerman NC, Norris DE. Molecular differentiation of metastriate tick immatures. Vector Borne and Zoonotic Diseases (Larchmont, N.Y.). 4: 334-42. PMID 15682516 DOI: 10.1089/Vbz.2004.4.334  0.3
Show low-probability matches.